THC Farmaceuticals, Inc.
CBDG · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $1 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $3 | $1 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 98.9% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | 90.5% | 100% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | -7.4% | 2,298.7% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | -8.4% | 1,149.3% |
| EPS Diluted | -0 | -0 | -0 | 0.004 |
| % Growth | 33.3% | -501.5% | -101.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |